Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lomecel-B in aging frailty
NCT02065245Phase 2Completed
- Sponsor
- Longeveron
- Start
- Mar 2014
- Primary completion
- Oct 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of laromestrocel in frailty syndrome, sponsored by Longeveron. Started Mar 2014; status: completed.
02
Drugs
laromestrocel
03
Conditions
frailty syndrome
Beyond the preview
Go deeper on NCT02065245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02065245.